• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IVX

INVION LIMITED - Charts / Financials

1.03% ! 9.6¢
Market Cap $8.199M  !
Healthcare Biotechnology
Add to My Watchlist

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 9.7¢   Day High 9.9¢   Day Low 9.5¢
Daily Volume 86227
Bids   Sellers
Number Price Volume   Number Price Volume
1 9.6¢ 20643   4 10.0¢ 256280

Directors & Senior Management

Mr. Thian C. Chew Executive Chairman of the Board, Chief Executive Officer
Ms. Melanie Jaye Leydin Company Secretary
Mr. Alistair Bennallack Non-Executive Director
Mr. Alan Yamashita Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
9.6¢ 		Change
-0.001(1.03%) 		Mkt cap ! $8.199M
Open High Low Value Volume
9.7¢ 9.9¢ 9.5¢ $8.335K 86.22K

Buyers (Bids)

No. Vol. Price($)
1 20643 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 256280 4
View Market Depth
Last trade - 14.40pm 28/07/2025 (20 minute delay) ?

Top Stories

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Boss Energy (ASX:BOE) is the first top-trender on HotCopper forums in Week 31, with the uranium producer wowing holders and traders alike with its FY26 guidance for its Honeymoon Operation in South Australia.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest ...
Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 30 epis...
ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28 The Australian sharemarket has shaken off a two-day red trend to close out Week 31’s first day up at around 8,700 points. Positive tariffs sentiments and a strengthening coin Down Under both helped the ASX to the green close.Listen to the HotCopper podcast for in-depth discussions...
Clarity confidence – and share price – up on bumper $203M institutional placement Clarity Pharmaceuticals (ASX:CU6) is heading towards Monday close up nearly +4% after the clinical-stage radiopharmaceutical company heralded the completion of a blockbuster $203 million institutional placement.Listen to the HotCopper podcast for in-depth discussions and insights on all the bigge...
Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon Boss Energy (ASX:BOE) has dived hard through Monday trade today, with the much-followed energy stock losing as much as -42% in value after warning shareholders there may be @potential challenges” hitting nameplate capacity coming at its Honeymoon uranium project in South Aus...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.